Atrial Fibrillation Market Size, Share, Trends 2015-2019

1
Global Atrial Fibrillation Market 2015-2019
2
Report Description
About Atrial Fibrillation According to the NHLBI
of the NIH in the US, atrial fibrillation is one
of the commonest type of arrhythmia. Atrial
fibrillation is similar to another type of
arrhythmia of the heart, superventricular
tachycardia. The chief difference between these
two types of arrhythmia is the consistency of the
beats. In superventricular tachycardia, the heart
beats are regular and at a very fast pace.
Patients with atrial fibrillation experience fast
and irregular heartbeats. In patients with atrial
fibrillation, electrical signals travel rapidly
in an uncontrolled way, which causes convulsion,
palpitation or contraction in the atria of the
heart. Blood is accumulated inside the atrial
chambers, instead of flowing to the ventricular
chambers. In this case, blood is not pumped into
the ventricles fully. Also, the quantity of blood
pumped out of the ventricles to the body is
irregular and centered on the arbitrary atrial
strokes. This can lead to the formation of blood
clot in the atria. Stroke occurs in case the clot
moves to the brain, which can cause death of an
individual. In atrial fibrillation, the
ventricles might beat for 100 to 175 times per
minute, which is a stark contrast to the normal
heart rate of 60 to 100 beats per minute. Atrial
fibrillation is more common in older people and
is detected using an ECG reading to find out the
abnormalities of the electric signal. Some of the
symptoms of atrial fibrillation are rapid and
irregular heartbeat, palpitations, dizziness,
sweating, chest pain, breathlessness, fatigue,
and sometimes loss of consciousness. Get
complete Report _at_ http//www.bigmarketresearch.co
m/global-atrial-fibrillation-2015-2019-market
3
Report Description
Global Atrial Fibrillation market to grow at a
CAGR of 11.05 percent over the period
2014-2019. Covered in this Report This report
covers the present scenario and the growth
prospects of the Global Atrial Fibrillation
market for the period 2015-2019. To calculate the
market size, the report considers the revenue
generated from the sales of various drugs such as
anti-arrythmics and anticoagulants used in the
treatment of atrial fibrillation. The report also
presents the vendor landscape and a corresponding
detailed analysis of the top vendors in the
Global Atrial Fibrillation market. The vendor
landscape section includes a market share
analysis of the major vendors along with the
performances of their product portfolios. In
addition, it discusses the major drivers that
influence the growth of the market. It also
outlines the challenges faced by the vendors and
the market at large, as well as the key trends
that are emerging in the market. Global Atrial
Fibrillation Market 2015-2019, has been prepared
based on an in-depth market analysis with inputs
from industry experts. The report covers the
Americas, and the EMEA and APAC regions it also
covers the Global Atrial Fibrillation market
landscape and its growth prospects in the coming
years. The report also includes a discussion of
the key vendors operating in this market. Enquire
About this report _at_ http//www.bigmarketresearch.c
om/report-enquiry/170893
4
Report Description
Key Regions Americas APAC EMEA
Key Vendors Boehringer Ingelheim Janssen
Pharmaceuticals Sanofi Other Prominent
Vendors ARCA Biopharma Armetheon
Baxter Bristol-Myers Squibb ChanRx Daiichi
Sankyo Gilead Sciences HUYA Biosciences
Menarini
5
Report Description
Market Driver Growing Patient Base For a
full, detailed list, view our report Market
Challenge High Cost of Therapy For a full,
detailed list, view our report Market Trend
Shifting Focus on Emerging Markets For a full,
detailed list, view our report Key Questions
Answered in this Report What will the market
size be in 2019 and what will the growth rate
be? What are the key market trends? What is
driving this market? What are the challenges to
market growth? Who are the key vendors in this
market space? What are the market opportunities
and threats faced by the key vendors? What are
the strengths and weaknesses of the key vendors?
6
Table of Contents
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Product
Profiles 05. Market Research Methodology 06.
Introduction 07. Disease Overview 08. Market
Landscape 09. Market Segmentation by Class of
Drugs 10. Geographical Segmentation 11. Buying
Criteria 12. Market Growth Drivers 13. Drivers
and their Impact 14. Market Challenges 15. Impact
of Drivers and Challenges 16. Market Trends 17.
Trends and their Impact 18. Vendor Landscape 19.
Key Vendor Analysis
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-atrial-fib
rillation-2015-2019-market
Stay With Us
TELEPHONE [phone] EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States